Statistics
Total Visits
| Views | |
|---|---|
| Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: A hellenic cooperative oncology group study | 179 |
Total Visits Per Month
| Φεβρουάριος 2024 | Μάρτιος 2024 | Απρίλιος 2024 | Μάϊος 2024 | Ιούνιος 2024 | Ιούλιος 2024 | Αύγουστος 2024 | |
|---|---|---|---|---|---|---|---|
| Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: A hellenic cooperative oncology group study | 1 | 25 | 0 | 8 | 4 | 4 | 5 |
Top country views
| Views | |
|---|---|
| Ηνωμένες Πολιτείες | 89 |
| Πολωνία | 54 |
| Κίνα | 8 |
| Σουηδία | 5 |
| Γαλλία | 3 |
| Ιρλανδία | 3 |
| Βραζιλία | 2 |
| Ινδία | 2 |
| Μογγολία | 2 |
| Ουκρανία | 2 |
Top cities views
| Views | |
|---|---|
| Warsaw | 54 |
| San Mateo | 25 |
| Louisville | 16 |
| Boardman | 7 |
| San Ramon | 7 |
| Ann Arbor | 6 |
| Ashburn | 4 |
| Beijing | 4 |
| Des Moines | 4 |
| Menlo Park | 4 |